The Varicose
veins treatments market was valued at USD 1.05 billion in 2021 and is projected
to reach USD 2.2 billion by 2032 at CAGR of 6% over the forecast period
2023-2032.
The varicose veins
treatment market continues to evolve with a focus on minimally
invasive procedures, driving growth globally. Innovations in endovenous laser
therapy, radiofrequency ablation, and sclerotherapy techniques characterize the
market. Increased awareness of cosmetic and health concerns related to varicose
veins fuels demand, especially among the aging population. Advancements in
technology, including ultrasound-guided procedures, enhance precision and
efficacy, attracting both patients and practitioners. Moreover, the market witnesses
strategic collaborations among healthcare providers and manufacturers to expand
product portfolios and geographical reach. With rising healthcare expenditures
and lifestyle-related factors contributing to venous disorders, the market is
poised for steady expansion.
The Varicose
Veins Treatment Market continues to witness significant growth propelled by
advancements in Varicose Vein Surgery and Vein Closure Techniques. Varicose
veins, characterized by swollen and twisted veins often occurring in the legs,
affect millions worldwide, driving the demand for effective treatment options.
Varicose Vein
Surgery remains a cornerstone in the management of varicose
veins, offering patients relief from discomfort and improving overall quality
of life. This procedure involves the removal or closure of affected veins
through surgical intervention. With technological innovations and minimally
invasive approaches, such as endovenous laser ablation and radiofrequency
ablation, Varicose Vein Surgery has become safer and more efficient, reducing
recovery times and patient discomfort.
Vein Closure
Techniques represent another vital aspect of varicose vein treatment. These
techniques aim to seal off diseased veins, rerouting blood flow to healthier
vessels. Methods such as sclerotherapy and vein ligation are commonly employed,
offering patients alternatives to traditional surgery with fewer complications
and faster recovery periods.
The market for
Varicose Veins Treatment is witnessing a paradigm shift towards minimally
invasive procedures, driven by patient preferences and technological
advancements. As awareness about varicose vein management increases and
healthcare infrastructures improve globally, the demand for innovative
treatment modalities like Varicose Vein Surgery and Vein Closure Techniques is
expected to soar, fostering a competitive yet dynamic market landscape.
Market
Segmentation
The varicose veins treatment device market is
segmented on the basis of type, product type and end user.
The market, depending on the type, has been
considered for endovenous ablation, sclerotherapy, surgical ligation, stripping
and laser ablations. The sclerotherapy segment has picked immense speed,
launching it ahead of other types of treatments. This holds true on the basis
of various benefits this treatment offers, such as less bruising and scarring;
no need for prolonged hospital stay, no need for sedation; positive
reimbursement policies as well as simple follow-up treatments.
The product-wise segments in the market are
ablation devices, venous closure products and surgical products. Ablation
devices are reckoned to be the dominating segment among all the products in the
global market, on account of their minimal invasive nature as well as speedy
recovery. Furthermore, venous closure products are predicted to rise at the
fastest growth rate.
The market, by end user, has been segmented
into hospitals, specialized clinics, ambulatory surgical centers and others.
Regional Outlook
The market for varicose veins treatment is
spread across the prominent regions of the Americas, Asia Pacific, Middle East
& Africa and Europe.
The Americas consists of smaller regional
markets of North America and South America for varicose veins treatment, where
the market in North America is divided into the United States (US) and Canada.
North America has launched into a clear leader in the global varicose vein
treatment market, with the backing of a number of factors including constantly
changing lifestyle, well-established health care infrastructure, rising health
care awareness, growing prevalence of varicose veins, increasing government spending,
high disposable income, and increasing importance of esthetics. Other than
this, supportive reimbursement policies, particularly in the U.S., have set in
motion the successful trajectory of the regional market.
The varicose veins treatment device market
in Europe is spread across Easter Europe and Western Europe, where Western
Europe is split into the countries of France, Germany, the United Kingdom (UK),
Spain, Italy, and the rest of Western Europe. High operative success rates,
elevating patient compliance and reliability, increasing healthcare
expenditure, along with the speedy growth in geriatric populace will create
commercial opportunities for the regional market in the near future.
The Asia Pacific varicose veins treatment
market is split into India, China, Japan, Australia, South Korea, and the rest
of the region. This is an opportune time for the region, as evident by the
increasing patient awareness, upward trend in the adoption of unhealthy
lifestyles, growing disposable income, and the growing benefits of early
treatments for varicose vein cases. The consistent and healthy growth of the
region will be apparent throughout the review period, with the strong support
from all these factors.
The Middle East & Africa varicose veins
treatment device market is fragmented into Middle East and Africa, and is
primarily driven by improving patient compliance on account of introduction of
durable and reliable techniques, as well as the constant efforts to improve the
healthcare infrastructure.
Companied Covered
The global varicose veins treatment companies are Merz North America Inc.,
Syneron Medical Ltd., AngioDynamics, Energist Ltd., Sciton Inc, Teleflex
Incorporated, Eufoton s.r.l., Quanta System, Medtronic, Scranton Gillette
Communications, Dornier MedTech, Fotona d.o.o., Lumenis, BTG International
Ltd., biolitec AG
Related Reports:
Chronic Lymphocytic Leukemia Treatment Market
ELISpot and FluoroSpot Assay Market
Clinical Trial Management System
Alzheimer’s disease Diagnostics
Biopsy Devices
For More Information, Please Visit @ Market Research Future
Comments
Post a Comment